Injecting tenecteplase into the artery after clot removal helps improve recovery in stroke survivors by enhancing blood flow ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms ...

Brainomix, an award-winning pioneer of state-of-the-art artificial intelligence (AI) imaging solutions, will be unveiling a ...

Eleven scientists will be recognized for their individual exceptional professional achievements and contributions to stroke care and research during the American Stroke Association’s International ...

Medtronic announced that new findings from the company-sponsored DiVERT Stroke clinical study showed women spent less time in t ...

Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 ...

For decades, taking a daily low-dose aspirin was a widely accepted practice for preventing heart attacks and strokes. But a ...